Related Experiment Video
Updated: Dec 12, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Sclerostin expression in trabecular bone is downregulated by osteoclasts
Masanori Koide1, Teruhito Yamashita1, Kohei Murakami2
1Division of Hard Tissue Research, Institute for Oral Science, Matsumoto Dental University, 1780 Gobara, Hiro-oka, Shiojiri, Nagano, 399-0781, Japan.
Abstract:
Bone tissues have trabecular bone with a high bone turnover and cortical bone with a low turnover. The mechanisms by which the turnover rate of these bone tissues is determined remain unclear. Osteocytes secrete sclerostin, a Wnt/β-catenin signaling antagonist, and inhibit bone formation. We found that sclerostin expression in cortical bone is more marked than in trabecular bone in Sost reporter mice. Leukemia inhibitory factor (LIF) secreted from osteoclasts reportedly suppressed sclerostin expression and promoted bone formation. Here, we report that osteoclasts downregulate sclerostin expression in trabecular bone and promote bone turnover. Treatment of C57BL/6 mice with an anti-RANKL antibody eliminated the number of osteoclasts and LIF-positive cells in trabecular bone. The number of sclerostin-positive cells was increased in trabecular bone, while the number of β-catenin-positive cells and bone formation were decreased in trabecular bone. Besides, Tnfsf11 heterozygous (Rankl+/-) mice exhibited a decreased number of LIF-positive cells and increased number of sclerostin-positive cells in trabecular bone. Rankl+/- mice exhibited a decreased number of β-catenin-positive cells and reduced bone formation in trabecular bone. Furthermore, in cultured osteoclasts, RANKL stimulation increased Lif mRNA expression, suggesting that RANKL signal increased LIF expression. In conclusion, osteoclasts downregulate sclerostin expression and promote trabecular bone turnover.
Insights
Osteoclasts promote trabecular bone turnover by downregulating sclerostin expression. This process involves Leukemia inhibitory factor (LIF) and is regulated by RANKL signaling, impacting bone formation.
Area of Science:
- Bone Biology
- Skeletal Physiology
- Cell Signaling
Background:
- Trabecular bone exhibits high turnover, while cortical bone has low turnover, but the regulatory mechanisms remain unclear.
- Osteocytes secrete sclerostin, a Wnt/β-catenin signaling antagonist, inhibiting bone formation.
- Leukemia inhibitory factor (LIF) from osteoclasts is known to suppress sclerostin and promote bone formation.
Purpose of the Study:
- To investigate the role of osteoclasts in regulating sclerostin expression and bone turnover in trabecular bone.
- To elucidate the involvement of Leukemia inhibitory factor (LIF) and RANKL signaling in this process.
Main Methods:
- Utilized Sost reporter mice and C57BL/6 mice treated with anti-RANKL antibody.
- Analyzed Tnfsf11 heterozygous (Rankl+/-) mice.
- Examined gene and protein expression (sclerostin, LIF, β-catenin) in bone tissues and cultured osteoclasts.
Main Results:
- Osteoclasts were found to downregulate sclerostin expression in trabecular bone, promoting bone turnover.
- Anti-RANKL treatment reduced osteoclasts, LIF-positive cells, and increased sclerostin-positive cells, while decreasing β-catenin and bone formation.
- Rankl+/- mice showed decreased LIF, increased sclerostin, and reduced β-catenin and bone formation in trabecular bone.
- RANKL stimulation in cultured osteoclasts increased Lif mRNA expression.
Conclusions:
- Osteoclasts play a crucial role in promoting trabecular bone turnover by downregulating sclerostin expression.
- The RANKL-LIF signaling pathway mediates the suppression of sclerostin by osteoclasts, thereby influencing bone formation and turnover.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Spongy Bone
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
Skeleton and Calcium Homeostasis

